Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algaecytes is a UK-based biotechnology company specializing in the production of high-value, sustainable ingredients derived from algae. The company utilizes a proprietary, closed-loop cultivation system to produce high-purity Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as well as proteins and antioxidants. Their products target the nutraceutical, pharmaceutical, and personal care markets, offering a vegan and environmentally friendly alternative to fish-derived oils. Algaecytes focuses on scalability and consistency to meet the growing global demand for sustainable health and wellness ingredients. The company is headquartered at Discovery Park in Kent, where it operates its research and production facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Algaecytes.